Dr. Sterman’s Clinical Practice
Dr. Daniel Sterman currently practices as an interventional pulmonologist at NYU Langone Health. He diagnoses and treats patients with lung cancer and malignant pleural mesothelioma at NYU Langone Pulmonary and Critical Care Associates and Perlmutter Cancer Center. Dr. Sterman also treats pleural effusion, a buildup of fluid between the membranes lining the lungs, which can result as a complication of these asbestos-related cancers.
Dr. Daniel Sterman practices a multidisciplinary approach to care. He works with a team of specialists including pathologists, thoracic medical oncologists, thoracic radiation oncologists, and thoracic surgeons. With this combination of expertise, he is able to provide his patients with the best care.
Research
Dr. Sterman studies gene therapy and immunotherapy for the treatment of thoracic malignancies. He has led multiple phase 1 human clinical trials as a principal investigator, studying gene therapy and vaccine therapy for lung cancer and mesothelioma. He has also studied novel diagnostics and treatments for peripheral lung cancers.
A Multidisciplinary Approach
Dr. Sterman practices a multidisciplinary approach to care. He works with a team of specialists including pathologists, thoracic medical oncologists, thoracic radiation oncologists, and thoracic surgeons. With this combination of expertise, he is able to provide his patients with the best care.
When faced with a diagnosis of an asbestos-related cancer like mesothelioma or lung cancer, it is crucial to find the right treatment right away. Contact Dr. Daniel Sterman today.